OnDemand
A Case-Base Approach to CV Risk Reduction with Icosapent Ethyl
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Agenda
  • Program Materials
  • Funding Support
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, and allied health professionals

program advertising tile
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, and allied health professionals

program advertising tile

This program is intended for primary care physicians, cardiologists, endocrinologists and lipidologists.

 

Through an interactive case-based discussion, this program will help practitioners identify the appropriate patient and timing for icosapent ethyl therapy to achieve additional cardiovascular risk reduction.

 

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

 

Alice Cheng
MD, FRCPC
Toronto, ON
Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Peter Lin
MD, CCFP
Toronto, ON
Program Chapter
Presenter
Introduction
Case 1: A patient with stable ASCVD and optimized LDL
Milan Gupta
Case 2: A patient with diabetes and additional risk factors
Alice Cheng
Case 3: A patient with ASCVD and elevated LDL and TG
Milan Gupta
Case 4: A patient with ASCVD with concomitant atrial fibrillation
Peter Lin
Conclusion

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Access CCRN Member Resource Library.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from:

 

© 2020-2021 MDLearn, All Rights are Reserved